Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.

During a vaccine clinical trial of Cytomegalovirus (CMV) vaccine, one of the participants' motivations was to prevent an infection responsible for malformations in a future child. Would their attitude towards a vaccine trial be the same in the context of a vaccine designed to protect them individually? By improving the knowledge of clinical research and determinants in women aged 18 to 40, this study could improve recruitment methods in this specific population for future vaccine trials within the CIC1408 infectious diseases and vaccinology area at Saint-Etienne University Hospital.

NCT Number	NCT06511635
Lead Sponsor	Centre Hospitalier Universitaire de Saint Etienne
Conditions	Recruitment
Enrollment	306 participants
Start Date	2024-09
Primary Completion	2024-11 (estimated)
Study Completion	2024-11 (estimated)
Updated on ClinicalTrials.gov	2024-07-22